T1	Participants 0 58	Simvastatin blunts endotoxin-induced tissue factor in vivo
T2	Participants 141 160	ascribed to statins
T3	Participants 281 383	A reductase inhibitors, as lipopolysaccharide (LPS)-induced monocyte tissue factor (TF) was suppressed
T4	Participants 596 740	20 healthy, male subjects were randomized to receive either simvastatin (80 mg/d) or placebo for 4 days before intravenous administration of LPS
T5	Participants 493 510	responses in vivo
T6	Participants 756 804	Plasma high-sensitive C-reactive protein (hsCRP)
T7	Participants 806 846	monocyte chemoattractant protein (MCP-1)
T8	Participants 919 968	ELISAs at baseline and at 4 and 8 hours after LPS
T9	Participants 1178 1242	significantly suppressed by statin treatment after LPS challenge
T10	Participants 1585 1720	Simvastatin suppresses the inflammatory response to endotoxin and blunts monocyte TF expression but does not affect platelet activation
T11	Participants 1410 1441	simvastatin after 4 and 8 hours
